Literature DB >> 7789184

Localization of the human stem cell tyrosine kinase-1 gene (FLT3) to 13q12-->q13.

C E Carow1, E Kim, A L Hawkins, H D Webb, C A Griffin, E W Jabs, C I Civin, D Small.   

Abstract

We have previously reported the cloning of stem cell tyrosine kinase-1 (STK-1, gene symbol FLT3), the human homolog of the mouse Flk2/Flt3 gene (Small et al., 1994). This growth factor receptor is expressed in CD34+ human bone marrow (stem/progenitor) cells. We have mapped the gene for STK-1 using PCR screening of a human-rodent somatic cell hybrid panel, and fluorescence in situ molecular hybridization (FISH) of STK-1 genomic probes to mitotic chromosomes of normal human lymphocytes. The results of both analyses show that the gene for STK-1 (FLT3) localizes to chromosome 13q12-->q13.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7789184     DOI: 10.1159/000134046

Source DB:  PubMed          Journal:  Cytogenet Cell Genet        ISSN: 0301-0171


  8 in total

1.  Treatment of FLT3-ITD acute myeloid leukemia.

Authors:  Amir T Fathi; Yi-Bin Chen
Journal:  Am J Blood Res       Date:  2011-09-09

Review 2.  Signal transduction of oncogenic Flt3.

Authors:  Chunaram Choudhary; Carsten Müller-Tidow; Wolfgang E Berdel; Hubert Serve
Journal:  Int J Hematol       Date:  2005-08       Impact factor: 2.490

3.  FLT3 inhibition as therapy in acute myeloid leukemia: a record of trials and tribulations.

Authors:  Amir T Fathi; Bruce A Chabner
Journal:  Oncologist       Date:  2011-07-17

Review 4.  Bench to bedside targeting of FLT3 in acute leukemia.

Authors:  Keith W Pratz; Mark J Levis
Journal:  Curr Drug Targets       Date:  2010-07       Impact factor: 3.465

Review 5.  Potential role of sorafenib in the treatment of acute myeloid leukemia.

Authors:  Shahram Mori; Jorge Cortes; Hagop Kantarjian; Weiguo Zhang; Michael Andreef; Farhad Ravandi
Journal:  Leuk Lymphoma       Date:  2008-12

Review 6.  The evolving role of FLT3 inhibitors in acute myeloid leukemia: quizartinib and beyond.

Authors:  Seth A Wander; Mark J Levis; Amir T Fathi
Journal:  Ther Adv Hematol       Date:  2014-06

7.  Role of misfolded N-CoR mediated transcriptional deregulation of Flt3 in acute monocytic leukemia (AML)-M5 subtype.

Authors:  Dawn Sijin Nin; Wai Kay Kok; Feng Li; Shinichiro Takahashi; Wee Joo Chng; Matiullah Khan
Journal:  PLoS One       Date:  2012-04-13       Impact factor: 3.240

Review 8.  An overview on the role of FLT3-tyrosine kinase receptor in acute myeloid leukemia: biology and treatment.

Authors:  Tiziana Grafone; Michela Palmisano; Chiara Nicci; Sergio Storti
Journal:  Oncol Rev       Date:  2012-04-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.